Joint Position Statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council…
The International Psoriasis Council (IPC) and the National Psoriasis Foundation (NPC) have released a joint position…
The International Psoriasis Council (IPC) and the National Psoriasis Foundation (NPC) have released a joint position…
View ReportHear from Psoriasis Experts in this Interview with IPC at the 2025 Chinese Dermatologist Association (CDA) Meeting in…
Watch VideoThe 2025 AAD Annual Meeting featured important updates on psoriasis therapies, comorbidities, and late-breaking…
View ReportThe 33rd Annual EADV Congress in Amsterdam featured updates on psoriasis care, including highlights from the IPC…
Read MoreINTERNATIONAL FEDERATION OF PSORIASIS ASSOCIATION CONFERENCE (IFPA) | STOCKHOLM, SWEDEN Friday, June 28 17:45 - 18:45…
The 2024 American Academy of Dermatology (AAD) Annual Meeting was held Thursday, March 7 – Tuesday, March 12, 2024,…
Read MoreDiscover the latest updates on psoriasis from the World Congress of Dermatology (WCD) 2023, hosted in Singapore from…
Read MoreThe patient perspective has become even more important in the wake of the pandemic. Here’s how Clinica Dermacross is…
Read MoreThirty-six statements on various aspects of telemedicine according to the nominal group technique to reach a consensus…
View ReportThe 2023 American Academy of Dermatology (AAD) Annual Meeting was held Thursday, March 16 – Tuesday, March 21, 2023,…
Read MoreThe 2023 American Academy of Dermatology (AAD) Annual Meeting was held Thursday, March 16 – Tuesday, March 21, 2023,…
View ReportThe Society of Investigative Dermatology (SID) Annual Meeting returned to an in-person format in 2022 for the first…
Read MoreView Report
The 2022 American Academy of Dermatology (AAD) Annual Meeting was held Thursday, March 24 – Tuesday, March 29 in…
Read MoreView Report
Having cared for psoriasis patients via teledermatology for more than 10 years prior to the pandemic, I recognize the…
Read More| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
IPC Jr. Councilor Towhida Noor reviews the psoriasis pipeline: selective TYK2 inhibitors, long-acting IL-17 and IL-23 biologics, and IL-36 blockade in GPP.
IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.
PRE-ORDER YOUR COPY
In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.
IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.